Abstract
While the Baculovirus Expression Vector System (BEVS) mainly uses insect cell lines, such as Sf9 cells, the robust high expression system using silkworm has also been developed. We have further improved technologies for enhancement of virus recombination, reduction of proteolytic degradation and aggregation, and more reliable promoters. These developments made it possible to achieve high and soluble expression of recombinant proteins. We review here such technology developments, advantage of using silkworm and some example applications. There are areas where this technology can be further improved as implicated in the end.
Keywords: Baculovirus, silkworm, polyhedrin, cathepsin-like protease, vp39, Dock-tag
Current Pharmaceutical Biotechnology
Title: Silkworm as a Host of Baculovirus Expression
Volume: 11 Issue: 3
Author(s): Akihiro Usami, Takeo Suzuki, Hidekazu Nagaya, Hiroki Kaki and Seiji Ishiyama
Affiliation:
Keywords: Baculovirus, silkworm, polyhedrin, cathepsin-like protease, vp39, Dock-tag
Abstract: While the Baculovirus Expression Vector System (BEVS) mainly uses insect cell lines, such as Sf9 cells, the robust high expression system using silkworm has also been developed. We have further improved technologies for enhancement of virus recombination, reduction of proteolytic degradation and aggregation, and more reliable promoters. These developments made it possible to achieve high and soluble expression of recombinant proteins. We review here such technology developments, advantage of using silkworm and some example applications. There are areas where this technology can be further improved as implicated in the end.
Export Options
About this article
Cite this article as:
Usami Akihiro, Suzuki Takeo, Nagaya Hidekazu, Kaki Hiroki and Ishiyama Seiji, Silkworm as a Host of Baculovirus Expression, Current Pharmaceutical Biotechnology 2010; 11 (3) . https://dx.doi.org/10.2174/138920110791112013
DOI https://dx.doi.org/10.2174/138920110791112013 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Cannabinoids and Endocannabinoids in Cerebral Ischemia
Current Pharmaceutical Design Bipolar Affective Disorder, Epilepsy and Migraine – Does Possible Shared Pathogenesis Explain their Association?
Current Psychopharmacology The Cellular Protective Effects of Rosmarinic Acid: From Bench to Bedside
Current Neurovascular Research The p35 Family of Apoptosis Inhibitors
Current Genomics Vasopressin in Health and Disease with a Focus on Affective Disorders
Central Nervous System Agents in Medicinal Chemistry mRNA as a Versatile Tool for Exogenous Protein Expression
Current Gene Therapy Demographic, Clinical and Laboratory Profiles of HIV Infected Patients Admitted into Imam Khomeini Hospital of Tehran, Iran
Infectious Disorders - Drug Targets Management of COVID-19 very Elderly Patients in Nursing Homes and Long-Term Care Facilities: Description of a New Model and Experience in a Medicalized Nursing Home
Coronaviruses Immunobiology of Antigen-Specific Immunoglobulin Free Light Chains in Chronic Inflammatory Diseases
Current Pharmaceutical Design Early Diagnosis of Multiple Sclerosis Based on Optical and Electrochemical Biosensors: Comprehensive Perspective
Current Analytical Chemistry Recent Advances and Approaches in Targeting Apoptosis Signaling Pathways for Anti-Cancer Therapeutics
Current Cancer Therapy Reviews Autoantibodies Associated with Psychiatric Disorders
Current Neurovascular Research Echinocandins for the Nursery: An Update
Current Drug Metabolism VEGF in Tumor Progression and Targeted Therapy
Current Cancer Drug Targets Therapeutic Perspectives of Drugs Targeting Toll-Like Receptors Based on Immune Physiopathology Theory of Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Annotating Viral Genomes - A Cannon is Needed to Kill Mosquitoes
Current Bioinformatics Improving Cognitive Outcome in Cerebral Malaria: Insights from Clinical and Experimental Research
Central Nervous System Agents in Medicinal Chemistry Antioxidant and Antimicrobial Activities of Cinnamic Acid Derivatives
Mini-Reviews in Medicinal Chemistry Inhibition of Viral-Induced Membrane Fusion by Peptides
Protein & Peptide Letters Immune Checkpoint Inhibitors and Neurotoxicity
Current Neuropharmacology